Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02208674 · ClinicalTrials.gov registry record · NA
Early Identification and Action in CKD
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT02208674 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 47 participants.
The verdict
NCT02208674, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
Chronic kidney disease (CKD) is highly prevalent and associated with significantly increased risk of cardiovascular morbidity and end-stage renal disease. Evidence from randomized clinical trials suggests that treating urinary albumin excretion (UAE), dyslipidemia, and hypertension will reduce these risks. Unfortunately, less than 30% of the CKD population is screened and treated according to recommended guidelines. Using a cluster-randomized, controlled design and clinic-embedded pharmacists, this pilot pragmatic trial will randomize 6 Geisinger primary care clinics (72 patients) to usual care (group 1) or a pharmacist-directed "CKD Action Plan" (group 2). Determining the impact of the CKD Action Plan on screening and treatment guideline adherence is the primary goal of this pilot study.
Interventions
- OTHER Protocolized, pharmacist-delivered CKD Action Plan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02208674
The ClinicalTrials.gov registry entry for NCT02208674 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Protocolized, pharmacist-delivered CKD Action Plan is the first listed.
NCT02208674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02208674 about?
NCT02208674 is a clinical study titled "Early Identification and Action in CKD". Chronic kidney disease (CKD) is highly prevalent and associated with significantly increased risk of cardiovascular morbidity and end-stage renal disease. Evidence from randomized clinical trials suggests that treating urinary albumin excretion (UAE), dyslipidemia, and hypertension will reduce these...
What is the current status of trial NCT02208674?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2014-09. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02208674?
The interventions under investigation include: Protocolized, pharmacist-delivered CKD Action Plan (OTHER).
Who is sponsoring clinical trial NCT02208674?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.